It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:

Bristol-Myers Squibb: "Bristol-Myers, we own a small position for the charitable trust. It is our smallest position, we do believe the stock will go lower. When it yields about 3.5 percent, and it yields 3 right now, maybe we pull the trigger and buy a little more. But not yet, the drug stocks are headed lower."

KKR & Co: "No, the dividend is not secure because it's now meant to fluctuate with the assets that they want to sell. And frankly, that is not an optimal situation for me. I would not make a big bet right here on KKR, because we don't know what they are up to."

Yum Brands: "No we are not holding or selling, we are a buyer of Yum Brands because the split is going to be good. They are going to turn a lot of capital and we have to think that this is just a great idea. A fast core from China, the rest of the world not as good but maybe give you a bigger dividend. Greg Creed [CEO] is doing it dead right."

Transocean Ltd: "I don't like Transocean because I don't like deep water. You've got Baker Hughes, you've got Halliburton. Those are better."

Insys Therapeutics: "This is a roll of the dice, 61 percent down, cancer therapeutic. Many of these stocks do not work out, but if you want to speculate, I'll bless it. Although I'm not crazy about it."

Monster Beverage Corp: "I have been a long-term supporter of Monster because they are taking share from the other guys and it is a very well-run company. But I'm not pressing it right now. The one I like to pound the table is Constellation Brands."

Sarepta Therapeutics: "I think that trade has come and gone and you should ring the register."

Scotts Miracle-Gro Co: "Scotts Miracle-Gro has been a winner right here, but I say be careful. We are a little late in the cycle for this one."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com